CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −4,321 | 8,205 | ||
| 2022-02-12 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −8,205 | 0 | ||
| 2022-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −4,395 | 20,727 | ||
| 2022-02-12 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −8,163 | 12,564 | ||
| 2022-02-12 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +263 | 1,488.89 | ||
| 2022-02-12 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −92 | $214.59 | $20K | 1,396.89 |
| 2022-02-12 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −263 | 1,245 | ||
| 2022-02-12 | Murphy Nicole Head of Pharm Ops and Tech | Other disposition · Restricted Stock Unit | −489 | 756 | ||
| 2022-02-10 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Grant or award · Restricted Stock Unit | +7,725 | 7,725 | ||
| 2022-02-10 | Gregory Ginger EVP, Human Resources | Grant or award · Restricted Stock Unit | +6,475 | 6,475 | ||
| 2022-02-10 | Guindo Chirfi Head of Glob Prod Strat & Com | Grant or award · Restricted Stock Unit | +9,090 | 9,090 | ||
| 2022-02-10 | Kramer Robin Chief Accounting Officer | Grant or award · Restricted Stock Unit | +2,500 | 2,500 | ||
| 2022-02-10 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Grant or award · Restricted Stock Unit | +9,770 | 9,770 | ||
| 2022-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Grant or award · Restricted Stock Unit | +6,815 | 6,815 | ||
| 2022-02-10 | Izzar Rachid Head of Alzheimer's Disease | Grant or award · Restricted Stock Unit | +4,545 | 4,545 | ||
| 2022-02-10 | Vounatsos Michel Chief Executive Officer | Grant or award · Restricted Stock Unit | +28,405 | 28,405 | ||
| 2022-01-19 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Grant or award | +658 | 5,064.13 | ||
| 2022-01-19 | Gregory Ginger EVP, Human Resources | Grant or award | +1,941 | 10,027.62 | ||
| 2022-01-19 | Guindo Chirfi Head of Glob Prod Strat & Com | Grant or award | +3,088 | 6,007 | ||
| 2022-01-19 | Kramer Robin Chief Accounting Officer | Grant or award | +244 | 1,354.35 |
Page 33 of 45 · 886 trades